Navigation Links
Medical doctors who do research could be a dying breed
Date:8/7/2008

The road from disease research to disease cure isn't usually a smooth one. One role which bridges the laboratory and the clinic is that of the "clinician-scientist" a doctor who understands disease both in the patient and in the Petri dish. Yet an editorial published in Disease Models & Mechanisms (DMM), http://dmm.biologists.org, contends that clinician-scientists in the UK and elsewhere are not prospering, but rather are "under threat in a hostile environment".

The editorial author, Dr Nick Lemoine, Director of the Cancer Research UK Clinical Centre and a clinician-scientist himself, believes that a lack of career support is partially to blame. Contrasting UK training programs to similar programs in the United States, he discusses how Britain's prospective doctors have fewer research training opportunities than their American counterparts. US dual-degree programs for a combined MD/PhD are comparatively well-funded. Additionally, follow-up studies show that graduates from US Medical Scientist Training Programs are successful in developing well-funded research careers. Clinician-scientists in the UK, however, lack a clear career structure, and are at a disadvantage compared to doctors who opt for traditional specialist training and seek out National Health Service posts.

Lemoine also calls attention to the major financial disadvantage of medical scientists in both countries. Pursuing an untraditional academic route adds a risk which is exacerbated by significant medical school debts. "Setting out on an academic path at qualification with a cloud of debt overhead is a brave move," Lemoine wrote, "and one that a diminishing proportion of graduates have been prepared to make."

However, the clinician-scientist environment might be changing in the UK, Lemoine observes. New funding is being allocated from both public organizations and private charities, and these sponsors are also deve
'/>"/>

Contact: Nick Birch
nick@biologists.com
44-122-342-6164
The Company of Biologists
Source:Eurekalert

Page: 1 2

Related biology news :

1. W.M. Keck Foundation announces 2008 class of Distinguished Young Scholars in Medical Research
2. NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008
3. Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
4. $2 million computer will help unravel major medical ailments
5. Glenn Foundation for Medical Research commits $5 million to study aging
6. New electrostatic-based DNA microarray technique could revolutionize medical diagnostics
7. First-ever symposium brings together military and civilian medical experts
8. NJIT biomedical engineer receives NSF Career Development Award
9. How to make microwaves on a chip to replace X-rays for medical imaging and security
10. 4 Stanford faculty named Howard Hughes Medical Institute Investigators
11. Engineer to spearhead research into cell metabolism and medical injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , June 27, 2014  Pomerantz LLP has ... Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) and certain ... United States District Court, Middle District of ... behalf of a class consisting of all persons ... securities between December 17, 2013 and May 22, ...
(Date:7/10/2014)... 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused ... Gino Pereira was interviewed on July 1 st ... Florida . Mr. Pereira discusses the company,s next generation ... and how the Wocket™ aims to replace a traditional wallet ... Cedric Harris tells Gino he has never heard of ...
(Date:7/10/2014)... July 8, 2014 Fingerprint ... new design win (DW). An Asian OEM has selected FPC1021 ... production start in August 2014.   FPC is ... which has a planned date for start of mass production ... order of SEK 5M, for delivery in the first half ...
Breaking Biology News(10 mins):SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2
... WI, JUNE 14, 2011 - Tropical maize proves to ... in USA Corn Belt maize. Most tropical maize varieties ... in U.S. growing regions by flowering late. This delayed ... useful genes and hindering their incorporation into maize hybrids ...
... our brain, and new research by University of California, ... that fear and other highly emotional experiences lead to ... (Tuesday, June 14) in advance of publication in the ... and colleagues report a new way for emotions to ...
... zone is predicted to be larger than average this ... this spring, according to an annual forecast by a ... Consortium, Louisiana State University and the University of Michigan. ... compiled annually by the U.S. Geological Survey (USGS). ...
Cached Biology News:Unique gene combinations control tropical maize response to day lengths 2Fear boosts activation of young, immature brain cells 2Fear boosts activation of young, immature brain cells 3Major flooding on the Mississippi River likely to cause large Gulf of Mexico dead zone 2Major flooding on the Mississippi River likely to cause large Gulf of Mexico dead zone 3
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... (PCR) TECHNOLOGY: GLOBAL MARKETS , the global market for ... billion in 2013. This is estimated to grow to ... growth rate (CAGR) of 28.6%. , New digital PCR ... possibilities within the broader PCR field. The opportunities presented ...
(Date:7/11/2014)...  Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
(Date:7/10/2014)... Product and process impurities in biopharmaceuticals ... are often “lost in the noise,” making their ... Dr. Rowel Tobias, Senior Scientist, Protein Chemistry at ... Quality at Nanotherapeutics, Inc., to lear about a ... and quantitation while achieving the required specificity and ...
(Date:7/10/2014)... July 10, 2014 Terascala, the industry ... that Alan Swahn, a former vice president of product ... as vice president of marketing. Terascala’s software when combined ... NetApp create the highest performance and most reliable solutions ... to guide Terascala’s channel expansion and broaden its product ...
Breaking Biology Technology:Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Terascala Expands Executive Team 2Terascala Expands Executive Team 3
... SectorWatch.biz announces the,availability of MarketStats on public ... today., Investors can view all of SectorWatch.biz ... -- Click on MarketStats, Today,s MarketStats on ... (OTC Bulletin Board: CVBT), Boston,Scientific Corp. (NYSE: ...
... Innovations Inc.,(TSX: ATB) will hold its quarterly conference ... February 29, 2008. The call will follow the ... year results issued earlier that,day. Participants may access ... or 800-731-5774 or via the Company,s website at, ...
... 14 Accelerated Community Oncology,Research Network, Inc. ... Phase,2b clinical trial evaluating the efficacy of ... drug gemcitabine (Gemzar(R)) in patients,with metastatic breast ... after,treatment with bevacizumab (Avastin(R))., (Logo: ...
Cached Biology Technology:SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA 2Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29 2Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx 2Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx 3
MpV17 transgene, murine homolog, glomerulosclerosis...
GEL FILTRATION CAL KIT HMW, 1 EA. *Category: Gel Filtration Gels....
... custom siRNA service provides the premium quality ... research. Custom siRNAs can be readily ordered ... target sequence, or by providing the sense ... Ambion's Silencer Validated and ...
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
Biology Products: